Search

Search Constraints

You searched for: Author/Creator Maschan, Alexey

Search Results

1. Additional flow cytometric studies for differential diagnosis between Burkitt lymphoma/leukemia and B-cell precursor acute lymphoblastic leukemia. (January 2021)

2. Blinatumomab following haematopoietic stem cell transplantation – a novel approach for the treatment of acute lymphoblastic leukaemia in infants. (11th April 2021)

3. Bortezomib induces long‐term remission in children with immune thrombotic thrombocytopenic purpura, refractory to plasma exchange, glucocorticoids, and rituximab: A report on two cases. Issue 4 (19th November 2020)

4. Brentuximab vedotin in the treatment of a patient with refractory Hodgkin disease and Proteus syndrome – a case report and discussion. Issue 7 (11th June 2015)

5. Chimerism evaluation in measurable residual disease‐suspected cells isolated by flow cell sorting as a reliable tool for measurable residual disease verification in acute leukemia patients after allogeneic hematopoietic stem cell transplantation. Issue 5 (28th December 2020)

6. Control of graft‐versus‐host disease with rabbit anti‐thymocyte globulin, rituximab, and bortezomib in TCRαβ/CD19‐depleted graft transplantation for leukemia in children: a single‐center retrospective analysis of two GVHD‐prophylaxis regimens. (3rd November 2019)

7. Efficacy and safety of a reduced dose of plerixafor in combination with granulocyte colony‐stimulating factor in healthy haploidentical stem cell donors. Issue 6 (24th March 2022)

8. Efficacy and safety of ruxolitinib in ineffective erythropoiesis suppression as a pretransplantation treatment for pediatric patients with beta‐thalassemia major. Issue 11 (14th September 2021)

9. Efficacy of romiplostim in treatment of thrombocytopenia in children with Wiskott–Aldrich syndrome. (31st October 2020)

10. FLAER‐negative CD15+ neutrophils can be used for the simplified screening of suspected PNH cases. (25th May 2020)